AI Verdict
NAGE has stronger fundamentals based on our AI analysis.
NAMSW vs NAGE Fundamental Comparison
| Metric | NAMSW | NAGE |
|---|---|---|
| Revenue | $22.5M | $129.4M |
| Net Income | $-203.8M | $17.4M |
| Net Margin | -905.7% | 13.4% |
| ROE | -29.8% | 22.7% |
| ROA | -26.5% | 16.3% |
| Current Ratio | 7.88x | 4.86x |
| Debt/Equity | 0.00x | 0.13x |
| EPS | $-1.72 | $0.20 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAMSW vs NAGE: Frequently Asked Questions
Is NAMSW or NAGE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NAGE has stronger fundamentals. NAMSW is rated STRONG SELL (88% confidence) while NAGE is rated BUY (78% confidence). This is not investment advice.
How does NAMSW compare to NAGE fundamentally?
NewAmsterdam Pharma Co N.V. has ROE of -29.8% vs Niagen Bioscience, Inc.'s 22.7%. Net margins are -905.7% vs 13.4% respectively.
Which stock pays higher dividends, NAMSW or NAGE?
NAMSW has a dividend yield of N/A or no dividend while NAGE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAMSW or NAGE for long term?
For long-term investing, consider that NAMSW has STRONG SELL rating with 88% confidence, while NAGE has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAMSW vs NAGE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAMSW vs NAGE, the AI consensus favors NAGE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.